Robotics in Healthcare - Thematic Intelligence
Description
Robotics in Healthcare - Thematic Intelligence
Summary
Macroeconomic factors will drive healthcare’s use of robotics
The healthcare industry, including pharma, medical devices, and healthcare providers and payors, is often risk-averse compared to other sectors when adopting new technologies. However, challenges such as COVID-19, environmental, social, and governance (ESG) issues, and aging populations are driving digital transformation. The use of robots to address these challenges will become crucial as increased demand for healthcare services coincides with heightened economic uncertainty.
Medical robots improve the standard of care
Healthcare providers will increasingly invest in medical robots to compensate for staff shortages and improve the standard of care. Care robots will dramatically cut the cost of nursing elderly patients, and even provide emotional support and human-like interaction. While surgical robots improve patient outcomes, reduce human error, and decrease the length of hospital stays. New surgical robotic models will provide entirely new surgical possibilities, for example, micro-robots will be used to treat difficult-to-treat diseases such as those in the brain.
Double-digit growth is expected in the next decade
Robotics is a fast-growing industry. GlobalData expects every segment of the robotics market to grow over the next decade. According to GlobalData forecasts, the medical robotics market was worth $4.7 billion in 2020, and by 2030, it will have grown at a compound annual growth rate (CAGR) of 12% to $14.5 billion. Surgical robots will drive the medical robotics market, bolstered by the growth of sales in orthopedic and neurosurgical robots.
Industrial robots will enhance smart pharma manufacturing
The deployment of robotics in manufacturing can lead to substantial enhancements beyond productivity increases, resulting in better compliance, consistency, and operational excellence. Adoption is still in the early stages, however, GlobalData’s Smart Pharma 2021 survey found that industry professionals believe robotics will be the most disruptive technology in pharma manufacturing processes. Deploying robots in manufacturing will enable the large-scale development of therapeutic products needed for emerging treatments such as cell & gene therapy.
Scope
Summary
Macroeconomic factors will drive healthcare’s use of robotics
The healthcare industry, including pharma, medical devices, and healthcare providers and payors, is often risk-averse compared to other sectors when adopting new technologies. However, challenges such as COVID-19, environmental, social, and governance (ESG) issues, and aging populations are driving digital transformation. The use of robots to address these challenges will become crucial as increased demand for healthcare services coincides with heightened economic uncertainty.
Medical robots improve the standard of care
Healthcare providers will increasingly invest in medical robots to compensate for staff shortages and improve the standard of care. Care robots will dramatically cut the cost of nursing elderly patients, and even provide emotional support and human-like interaction. While surgical robots improve patient outcomes, reduce human error, and decrease the length of hospital stays. New surgical robotic models will provide entirely new surgical possibilities, for example, micro-robots will be used to treat difficult-to-treat diseases such as those in the brain.
Double-digit growth is expected in the next decade
Robotics is a fast-growing industry. GlobalData expects every segment of the robotics market to grow over the next decade. According to GlobalData forecasts, the medical robotics market was worth $4.7 billion in 2020, and by 2030, it will have grown at a compound annual growth rate (CAGR) of 12% to $14.5 billion. Surgical robots will drive the medical robotics market, bolstered by the growth of sales in orthopedic and neurosurgical robots.
Industrial robots will enhance smart pharma manufacturing
The deployment of robotics in manufacturing can lead to substantial enhancements beyond productivity increases, resulting in better compliance, consistency, and operational excellence. Adoption is still in the early stages, however, GlobalData’s Smart Pharma 2021 survey found that industry professionals believe robotics will be the most disruptive technology in pharma manufacturing processes. Deploying robots in manufacturing will enable the large-scale development of therapeutic products needed for emerging treatments such as cell & gene therapy.
Scope
- This report is a thematic brief, which identifies those companies most likely to succeed in a world filled with disruptive threats.
- Inside, we predict how each theme will evolve and identify the leading and disrupting companies.
- The report covers the Robotics theme.
- GlobalData’s thematic research ecosystem is a single, integrated global research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors. It has a proven track record of identifying the important themes early, enabling companies to make the right investments ahead of the competition, and secure that all-important competitive advantage.
- Develop and design your corporate strategies through an in-house expert analysis of robotics by understanding the primary ways in which this theme is impacting the medical devices industry.
- Stay up to date on the industry’s major players and where they sit in the value chain.
- Identify emerging industry trends to gain a competitive advantage.
Table of Contents
90 Pages
- Executive Summary
- Key players in the robotics value chain
- Robot manufacturing
- Hardware components
- Software components
- R-obotics as a service
- Figure 17: Trend analysis of the leading themes mentioned by influencers in the healthcare, medical devices, and pharma sectors
- Key challenges facing the healthcare sector
- Figure 18: Thematic impact assessment for medical devices
- Figure 19: Thematic impact assessment for pharma
- Figure 20: Thematic impact assessment for healthcare (healthcare providers and payors)
- How robotics helps resolve the challenge of COVID-19
- How robotics helps resolve the challenge of ESG
- How robotics helps resolve the challenge of aging populations
- How robotics helps resolve the challenge of staff and skills shortages
- How robotics helps resolve the challenge of drug discovery and development
- How robotics helps resolve the challenge of smart manufacturing
- How robotics helps resolve the challenge of last-mile delivery
- Hunjan Hospital deployed an orthopedic surgical robot for knee replacement surgery
- Eli Lilly automates drug discovery with a remote-controlled robotic cloud lab
- Bionaut Labs creates remote-controlled micro-robots to target brain diseases
- Multiply Labs is coordinating a consortium to automate cell therapy manufacturing
- Aurolab increased the production of its cataract kit with industrial co-bots
- Brain Navi developed an AI-powered robotic arm to conduct COVID-19 tests
- Matternet launched a medical drone network in Abu Dhabi
- Market size and growth forecasts
- Mergers and acquisitions
- Capital raising
- Patent trends
- Company filings trends
- Hiring trends
- Social media trends
- Robotics timeline
- Leading robotics adopters in healthcare
- Leading robotics vendors
- Specialist robotics vendors in healthcare
- Medical devices sector scorecard
- Drug manufacturing sector scorecard
- Glossary
- GlobalData reports
- Figure 52: Our five-step approach for generating a sector scorecard
- About GlobalData
- Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
